These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan. Chien YH; Lee NC; Weng WC; Chen LC; Huang YH; Wu CS; Hwu WL Neurol Sci; 2022 Jul; 43(7):4563-4566. PubMed ID: 35562557 [TBL] [Abstract][Full Text] [Related]
4. Improving recognition of Duchenne muscular dystrophy: a retrospective case note review. van Ruiten HJ; Straub V; Bushby K; Guglieri M Arch Dis Child; 2014 Dec; 99(12):1074-7. PubMed ID: 25187493 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy. Moat SJ; Korpimäki T; Furu P; Hakala H; Polari H; Meriö L; Mäkinen P; Weeks I Clin Chem; 2017 Apr; 63(4):908-914. PubMed ID: 28209627 [TBL] [Abstract][Full Text] [Related]
6. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study. Tavakoli NP; Gruber D; Armstrong N; Chung WK; Maloney B; Park S; Wynn J; Koval-Burt C; Verdade L; Tegay DH; Cohen LL; Shapiro N; Kennedy A; Noritz G; Ciafaloni E; Weinberger B; Ellington M; Schleien C; Spinazzola R; Sood S; Brower A; Lloyd-Puryear M; Caggana M; Ann Clin Transl Neurol; 2023 Aug; 10(8):1383-1396. PubMed ID: 37350320 [TBL] [Abstract][Full Text] [Related]
7. Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina. Kucera KS; Boyea BL; Migliore B; Potter SN; Robles VR; Kutsa O; Cope H; Okoniewski KC; Wheeler A; Rehder CW; Smith EC; Peay HL Genet Med; 2024 Jan; 26(1):101009. PubMed ID: 37864479 [TBL] [Abstract][Full Text] [Related]
8. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story. Scheuerbrandt G Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144 [TBL] [Abstract][Full Text] [Related]
9. Creatine kinase-MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy. Park S; Maloney B; Caggana M; Tavakoli NP Muscle Nerve; 2022 Jun; 65(6):652-658. PubMed ID: 35307847 [TBL] [Abstract][Full Text] [Related]
10. [Screening for Duchenne muscular dystrophy in newborns in the Ningxia region]. Jing M; Wang Y; Jing XY; Mao XM Zhongguo Dang Dai Er Ke Za Zhi; 2024 Mar; 26(3):258-261. PubMed ID: 38557377 [TBL] [Abstract][Full Text] [Related]
11. Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing. Han S; Xu H; Zheng J; Sun J; Feng X; Wang Y; Ye W; Ke Q; Ren Y; Yao S; Zhang S; Chen J; Griggs RC; Zhao Z; Qi M; Gatheridge MA Biomed Res Int; 2020; 2020():8396429. PubMed ID: 33029525 [TBL] [Abstract][Full Text] [Related]
12. Experience with screening newborns for Duchenne muscular dystrophy in Wales. Bradley DM; Parsons EP; Clarke AJ BMJ; 1993 Feb; 306(6874):357-60. PubMed ID: 8461680 [TBL] [Abstract][Full Text] [Related]
13. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Mendell JR; Shilling C; Leslie ND; Flanigan KM; al-Dahhak R; Gastier-Foster J; Kneile K; Dunn DM; Duval B; Aoyagi A; Hamil C; Mahmoud M; Roush K; Bird L; Rankin C; Lilly H; Street N; Chandrasekar R; Weiss RB Ann Neurol; 2012 Mar; 71(3):304-13. PubMed ID: 22451200 [TBL] [Abstract][Full Text] [Related]
14. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening. Hauser E; Toifl K; Mad A; Bittner R Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369 [TBL] [Abstract][Full Text] [Related]
15. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus. Drousiotou A; Ioannou P; Georgiou T; Mavrikiou E; Christopoulos G; Kyriakides T; Voyasianos M; Argyriou A; Middleton L Genet Test; 1998; 2(1):55-60. PubMed ID: 10464597 [TBL] [Abstract][Full Text] [Related]
16. Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption. Parad RB; Sheldon Y; Bhattacharjee A Int J Neonatal Screen; 2021 Nov; 7(4):. PubMed ID: 34842620 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy. Maloney B; Park S; Sowizral M; Brackett I; Moslehi R; Chung WK; Gruber D; Brower A; Lloyd-Puryear M; Caggana M; Tavakoli NP Clin Biochem; 2023 Aug; 118():110614. PubMed ID: 37479106 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Creatine Kinase Isoenzyme-MM Test in Newborn Screening for Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis. Tang L; Pan M; Wu F Pediatr Neurol; 2024 Apr; 153():84-91. PubMed ID: 38350306 [TBL] [Abstract][Full Text] [Related]
20. Duchenne muscular dystrophy: issues in expanding newborn screening. Kemper AR; Wake MA Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]